|
ENTX Entera Bio Ltd 1638097 |
| Income Statement |
|
Revenue
|
zk2432201
|
42,000 |
|
Net Income
|
zk2432201
|
-3,021,000 |
|
Profit Margin
|
|
-7192.86% |
| Balance Sheet |
|
Current Assets
|
7,340,000 |
|
Assets
|
7,741,000 |
|
Current Liabilities
|
1,111,000 |
|
Liabilities
|
1,289,000 |
|
Equity
|
6,452,000 |
|
Shares Out
|
36,325,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,351,000 |
| Market Analysis |
Market Cap
|
76,434,156 |
|
Price
|
1.95 |
|
BVPS
|
0.18 |
|
PB
|
11.09 |
|
EPS
|
-0.26 |
|
PS
|
454.97 |
|
FCF
|
-5,351,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENTX documents filed with the SEC.
ENTX Filings
Clear
